Cargando…

Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease

Fatigue is frequently reported by patients with multiple sclerosis, aquaporin-4-antibody neuromyelitis optica spectrum disorder and myelin-oligodendrocyte-glycoprotein antibody disease; thus they could share a similar pathophysiological mechanism. In this cross-sectional cohort study, we assessed th...

Descripción completa

Detalles Bibliográficos
Autores principales: Camera, Valentina, Mariano, Romina, Messina, Silvia, Menke, Ricarda, Griffanti, Ludovica, Craner, Matthew, Leite, Maria I, Calabrese, Massimiliano, Meletti, Stefano, Geraldes, Ruth, Palace, Jacqueline A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171455/
https://www.ncbi.nlm.nih.gov/pubmed/37180990
http://dx.doi.org/10.1093/braincomms/fcad107
_version_ 1785039421307879424
author Camera, Valentina
Mariano, Romina
Messina, Silvia
Menke, Ricarda
Griffanti, Ludovica
Craner, Matthew
Leite, Maria I
Calabrese, Massimiliano
Meletti, Stefano
Geraldes, Ruth
Palace, Jacqueline A
author_facet Camera, Valentina
Mariano, Romina
Messina, Silvia
Menke, Ricarda
Griffanti, Ludovica
Craner, Matthew
Leite, Maria I
Calabrese, Massimiliano
Meletti, Stefano
Geraldes, Ruth
Palace, Jacqueline A
author_sort Camera, Valentina
collection PubMed
description Fatigue is frequently reported by patients with multiple sclerosis, aquaporin-4-antibody neuromyelitis optica spectrum disorder and myelin-oligodendrocyte-glycoprotein antibody disease; thus they could share a similar pathophysiological mechanism. In this cross-sectional cohort study, we assessed the association of fatigue with resting-state functional MRI, diffusion and structural imaging measures across these three disorders. Sixteen patients with multiple sclerosis, 17 with aquaporin-4-antibody neuromyelitis optica spectrum disorder and 17 with myelin-oligodendrocyte-glycoprotein antibody disease assessed, outside of relapses, at the Oxford Neuromyelitis Optica Service underwent Modified Fatigue Impact Scale, Hospital Anxiety and Depression Scale and Expanded Disability Status Scale scoring. A 3T brain and spinal cord MRI was used to derive cortical, deep grey and white matter volumetrics, lesions volume, fractional anisotropy, brain functional connectivity metrics, cervical spinal cord cross-sectional area, spinal cord magnetic transfer ratio and average functional connectivity between the ventral and the dorsal horns of the cervical cord. Linear relationships between MRI measures and total-, cognitive- and physical-fatigue scores were assessed. All analyses were adjusted for correlated clinical regressors. No significant differences in baseline clinical characteristics, fatigue, depression and anxiety questionnaires and disability measures were seen across the three diseases, except for older age in patients with aquaporin-4-antibody neuromyelitis optica spectrum disorder (P = 0.0005). In the total cohort, median total-fatigue score was 35.5 (range 3–72), and 42% of patients were clinically fatigued. A positive correlation existed between the total-fatigue score and functional connectivity of the executive/fronto-temporal network in the in left middle temporal gyrus (P = 0.033) and between the physical-fatigue score and functional connectivity of the sensory-motor network (P = 0.032) in both pre- and post-central gyri. A negative relationship was found between the total-fatigue score and functional connectivity of the salience network (P = 0.023) and of the left fronto-parietal network (P = 0.026) in the right supramarginal gyrus and left superior parietal lobe. No clear relationship between fatigue subscores and the average functional connectivity of the spinal cord was found. Cognitive-fatigue scores were positively associated with white matter lesion volume (P = 0.018) and negatively associated with white matter fractional anisotropy (P = 0.032). Structural, diffusion and functional connectivity alterations were not influenced by the disease group. Functional and structural imaging metrics associated with fatigue relate to brain rather than spinal cord abnormalities. Salience and sensory-motor networks alterations in relation to fatigue might indicate a disconnection between the perception of the interior body state and activity and the actual behavioural responses and performances (reversible or irreversible). Future research should focus on functional rehabilitative strategies.
format Online
Article
Text
id pubmed-10171455
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101714552023-05-11 Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease Camera, Valentina Mariano, Romina Messina, Silvia Menke, Ricarda Griffanti, Ludovica Craner, Matthew Leite, Maria I Calabrese, Massimiliano Meletti, Stefano Geraldes, Ruth Palace, Jacqueline A Brain Commun Original Article Fatigue is frequently reported by patients with multiple sclerosis, aquaporin-4-antibody neuromyelitis optica spectrum disorder and myelin-oligodendrocyte-glycoprotein antibody disease; thus they could share a similar pathophysiological mechanism. In this cross-sectional cohort study, we assessed the association of fatigue with resting-state functional MRI, diffusion and structural imaging measures across these three disorders. Sixteen patients with multiple sclerosis, 17 with aquaporin-4-antibody neuromyelitis optica spectrum disorder and 17 with myelin-oligodendrocyte-glycoprotein antibody disease assessed, outside of relapses, at the Oxford Neuromyelitis Optica Service underwent Modified Fatigue Impact Scale, Hospital Anxiety and Depression Scale and Expanded Disability Status Scale scoring. A 3T brain and spinal cord MRI was used to derive cortical, deep grey and white matter volumetrics, lesions volume, fractional anisotropy, brain functional connectivity metrics, cervical spinal cord cross-sectional area, spinal cord magnetic transfer ratio and average functional connectivity between the ventral and the dorsal horns of the cervical cord. Linear relationships between MRI measures and total-, cognitive- and physical-fatigue scores were assessed. All analyses were adjusted for correlated clinical regressors. No significant differences in baseline clinical characteristics, fatigue, depression and anxiety questionnaires and disability measures were seen across the three diseases, except for older age in patients with aquaporin-4-antibody neuromyelitis optica spectrum disorder (P = 0.0005). In the total cohort, median total-fatigue score was 35.5 (range 3–72), and 42% of patients were clinically fatigued. A positive correlation existed between the total-fatigue score and functional connectivity of the executive/fronto-temporal network in the in left middle temporal gyrus (P = 0.033) and between the physical-fatigue score and functional connectivity of the sensory-motor network (P = 0.032) in both pre- and post-central gyri. A negative relationship was found between the total-fatigue score and functional connectivity of the salience network (P = 0.023) and of the left fronto-parietal network (P = 0.026) in the right supramarginal gyrus and left superior parietal lobe. No clear relationship between fatigue subscores and the average functional connectivity of the spinal cord was found. Cognitive-fatigue scores were positively associated with white matter lesion volume (P = 0.018) and negatively associated with white matter fractional anisotropy (P = 0.032). Structural, diffusion and functional connectivity alterations were not influenced by the disease group. Functional and structural imaging metrics associated with fatigue relate to brain rather than spinal cord abnormalities. Salience and sensory-motor networks alterations in relation to fatigue might indicate a disconnection between the perception of the interior body state and activity and the actual behavioural responses and performances (reversible or irreversible). Future research should focus on functional rehabilitative strategies. Oxford University Press 2023-04-04 /pmc/articles/PMC10171455/ /pubmed/37180990 http://dx.doi.org/10.1093/braincomms/fcad107 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Camera, Valentina
Mariano, Romina
Messina, Silvia
Menke, Ricarda
Griffanti, Ludovica
Craner, Matthew
Leite, Maria I
Calabrese, Massimiliano
Meletti, Stefano
Geraldes, Ruth
Palace, Jacqueline A
Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
title Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
title_full Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
title_fullStr Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
title_full_unstemmed Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
title_short Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
title_sort shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and mog antibody disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171455/
https://www.ncbi.nlm.nih.gov/pubmed/37180990
http://dx.doi.org/10.1093/braincomms/fcad107
work_keys_str_mv AT cameravalentina sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT marianoromina sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT messinasilvia sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT menkericarda sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT griffantiludovica sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT cranermatthew sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT leitemariai sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT calabresemassimiliano sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT melettistefano sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT geraldesruth sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease
AT palacejacquelinea sharedimagingmarkersoffatigueacrossmultiplesclerosisaquaporin4antibodyneuromyelitisopticaspectrumdisorderandmogantibodydisease